
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Advanced Gastroenteropancreatic Neuroendocrine Tumor
View Full LandscapeTarget Indication
Advanced Gastroenteropancreatic Neuroendocrine Tumor
Clinical Trial
NCT06091748Last updated: 1/2/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
KNEE OSTEOARTHRITIS
Advanced Solid Tumor
Carcinoma, Hepatocellular
PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer
Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based Therapy